Montelukast as add-on therapy with inhaled corticosteroids or inhaled corticosteroids and long-acting beta-2-agonists in the management of patients diagnosed with asthma and concurrent allergic rhinitis (the RADAR trial)

Lignende værker

• Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial)
  af: Paul K Keith, et al.
  Udgivet: (2009-01-01)
• Montelukast as add-on therapy to inhaled corticosteroids in the management of asthma (the SAS trial)
  af: FitzGerald, J Mark, et al.
  Udgivet: (2009)
• Montelukast as Add-On Therapy to Inhaled Corticosteroids in the Management of Asthma (The SAS Trial)
  af: J Mark FitzGerald, et al.
  Udgivet: (2009-01-01)
• Montelukast as an alternative to low-dose inhaled corticosteroids in the management of mild asthma (the SIMPLE trial): An open-label effectiveness trial
  af: McIvor, R Andrew, et al.
  Udgivet: (2009)
• Montelukast as an Alternative to Low-Dose Inhaled Corticosteroids in the Management of Mild Asthma (The SIMPLE Trial): An Open-Label Effectiveness Trial
  af: R Andrew McIvor, et al.
  Udgivet: (2009-01-01)